Drug intelligence / Profile preview

Progepril

Development stage
Unknown
Lead developer
Named Group
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Progepril is a multi-ingredient botanical dietary supplement formulated to manage menstrual cycle irregularities and symptoms of premenstrual syndrome (PMS). It contains extracts of *Dioscorea villosa* (Wild Yam), *Vitex agnus-castus* (Chasteberry), and *Turnera diffusa* (Damiana). The supplement is particularly utilized in women for whom synthetic hormonal treatments are contraindicated, such as breast cancer survivors or individuals with high genetic risk for breast cancer. Its mechanism involves the phyto-progestogenic properties of its components; specifically, *Vitex agnus-castus* contains dopaminergic compounds that bind to pituitary dopamine D2 receptors, leading to a reduction in prolactin secretion and stabilization of the luteal phase. *Dioscorea villosa* provides diosgenin, a plant steroid often associated with progesterone-like effects. Together, these ingredients work to regularize menstrual flow and duration while alleviating psychophysical symptoms associated with the menstrual cycle.

Brand names
Progepril
Other names
Progepril
02

Targets

PR (Progesterone receptor)DRD2 (Dopamine D2 Receptor)PRLR (Prolactin receptor)

Beyond the preview

Go deeper on Progepril.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progepril.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call